AlphaDERA Labs specializes in innovative clinical testing and diagnostics, leveraging state-of-the-art facilities and a team of experienced professionals to provide optimized clinical testing solutions. Their offerings include a comprehensive range of services such as on-demand testing, which allows patients to take control of their health through home sample collection and accessible patient service centers. The lab emphasizes personalized medication through advanced pharmacogenomic testing, which analyzes an individual's genetic makeup to inform optimal treatment strategies. Additionally, AlphaDERA Labs employs Next Generation Sequencing (NGS) technology to empower precision healthcare, aiming to address 100 rare diseases within a decade.

The company also provides a robust menu of clinical chemistry and immunoassays, featuring over 160 assays and testing panels that cater to various healthcare needs. Their commitment to accuracy and reliability is supported by cutting-edge analytical technology, ensuring consistent results across multiple sample types. Furthermore, AlphaDERA Labs plays a vital role in supporting clinical trials and drug development, utilizing advanced technologies for biomarker detection and toxicology studies. This comprehensive approach positions AlphaDERA Labs as a trusted partner in the healthcare ecosystem, dedicated to delivering high-quality care and informed health choices for patients and organizations alike.

United States

AlphaDERA Labs, LLC. is a full-service medical laboratory providing wellness testing, routine blood chemistry, prescription & illicit drug test including urinary tract testing, respiratory pathogen testing, and COV-19 antigen testing for healthcare facilities, clinics, and PCR Covid-19 testing for patients.

Alphadera Labs

Company Details